Companies Say Connecticut AG Investigates Pricing of Generic Digoxin

Impax Laboratories Inc. July 15 said that it received a subpoena and interrogatories from the Connecticut attorney general’s office relating to the company’s sales of generic digoxin.

Separately, another generic drug company, Lannett Co., said in a July 16 statement it “received interrogatories and subpoena from the State of Connecticut Office of the Attorney General concerning its investigation into pricing of digoxin.”

In an 8-K filing with the Securities and Exchange Commission, Impax said Connecticut Attorney General George Jepsen (D) is looking into the possibility of antitrust violations—specifically, price fixing—in the digoxin market.

“According to the Connecticut AG, the investigation ...